My practice offers buprenorphine (Suboxone) assisted treatment of opioid dependence. We have developed a comprehensive program which includes group therapy, and treatment of co-occuring psychiatric conditions with individual therapy and medication as indicated. I am pleased to collaborate with Ms. Nell Corry, a skilled addiction specialist who provides group therapy to my patients. In order to provide an experience which is as supportive and productive as possible, each group is limited to no more than 10 participants. Our program is very cost-effective in comparison to large clinics which generally charge significantly more and are simply not equipped to provide the same level of personalized treatment.
All patients receive a comprehensive psychiatric and addiction assessment. In-office urine drug screening is performed during this and subsequent appointments. After determining that it is indeed appropriate to proceed with buprenorphine treatment, I generally give patients one week’s supply of medication along with written instructions on how to get started with the medication. I also give patients a prescription for labwork in order to screen for conditions such as Hepatitis B and C, HIV, and liver toxicity, which can co-occur in patients with opioid addiction.
One week later, patients come in for a medication management appointment in which the dosage is fine-tuned as necessary. Assuming they have been able to maintain abstinence from opioids and other substances of abuse, patients are then transitioned to the following schedule:
- Monthly medication management appointments, including an in-office urine drug screen.
- Four weekly group therapy sessions per month.
Treatment at this level is provided at a total cost of $325 per month. Patients who have health insurance are given receipts with which to file, and are usually reimbursed a significant portion of the cost.
The treatment plan can be adjusted to include individual psychotherapy and/or more frequent medication management appointments depending on the needs of the patient.
If you are interested in making a new patient appointment, please contact the office by email or phone. Mary Beth, the office manager, does a brief screening over the phone before setting up appointments with new patients. The purpose of the screening is to ensure that we believe we can be of assistance to you before proceeding.
Prior to the initial appointment, please review the Buprenorphine Information and Buprenorphine Consent forms. Please bring the latter form to your appointment so that it may be completed after the initial assessment, assuming it is appropriate to proceed with treatment. Please also complete and bring the general forms listed on the Appointments page prior to the first appointment